28 Apr 2026 – Intimation regarding receipt of EU GMP Certificate for Sterile Product Division
29th April 2026
Stock Exchange Intimation
29 Apr 2026 – OneSource’s Partner Dr. Reddy’s Laboratories receives Health Canada Approval for Generic Semaglutide Injection
29th April 2026
Stock Exchange Intimation
21 Apr 2026 – Orbicular’s Partner secures tentative U.S. ANDA approval for a generic version of Ozempic® (Semaglutide Injection), supported by OneSource as CDMO partner
21st April 2026
Stock Exchange Intimation
17 Apr 2026 – Intimation of the renewal of EU GMP Certification for OneSource: Flagship Unit II Facility located in Bengaluru
17th April 2026
Stock Exchange Intimation
16 Apr 2026 – Intimation of ESG Rating received from NSE Sustainability Ratings and Analytics Limited
17th April 2026
Stock Exchange Intimation
9 Apr 2026 – Allotment of 21,450 equity shares under ONESOURCE ESOP Scheme 2021
13th April 2026
Stock Exchange Intimation
25 Mar 2026 – Intimation regarding closure of Trading Window
25th March 2026
Stock Exchange Intimation
20 Mar 2026 – Disclosure under Regulation 46 of the SEBI (LODR) Regulations, 2015